Mycoplasma Genitalium: Symptoms, Testing, and Treatment

It may infect the:

• urethra;
• cervix;
• reproductive tract.

Possible symptoms include:

• burning during urination;
• genital discharge;
• pelvic pain;
• bleeding after sex;
• pain during sex.

Many people have no symptoms, so infection can be present without being noticed.

Mycoplasma refers to a group of very small bacteria without a typical cell wall, while genitalium reflects its association with the genital tract.

Examples include:

• She tested positive for Mycoplasma genitalium.
• M. genitalium can cause persistent urethritis.
• The clinician ordered testing for Mgen.

Common expressions include:

• Mgen infection;
• M. genitalium testing;
• Mgen treatment;
• persistent urethritis;
• antibiotic-resistant Mgen.

Transmission can occur through:

• vaginal sex;
• anal sex;
• other genital contact involving infected secretions.

A person may transmit the infection even without symptoms.

The exact risk associated with different sexual practices varies, but genital and rectal exposure can be important.

Possible symptoms include:

• burning or pain during urination;
• urethral discharge;
• irritation at the opening of the penis;
• persistent or recurrent urethritis.

Some people have no symptoms.

Mgen may be considered when urethritis continues after more common causes, such as gonorrhea or chlamydia, have been excluded or treated.

Possible symptoms include:

• unusual vaginal discharge;
• bleeding after sex;
• bleeding between periods;
• pelvic discomfort;
• pain during sex.

Many infections remain asymptomatic.

Because symptoms overlap with chlamydia, gonorrhea, and other conditions, laboratory testing is often needed.

PID occurs when infection spreads into the upper reproductive tract.

Possible symptoms include:

• lower abdominal pain;
• pelvic pain;
• abnormal bleeding;
• pain during sex;
• fever in some cases.

Untreated PID can affect reproductive health.

The exact contribution of Mgen to long-term complications is still being studied, but it is recognized as an important cause of reproductive-tract inflammation.

Both may cause:

• urethritis;
• cervicitis;
• painful urination;
• discharge;
• few or no symptoms.

However, they are caused by different bacteria and may require different antibiotics.

Mgen is especially important because antibiotic resistance can make treatment more complicated.

Gonorrhea may produce more obvious discharge in some people, but symptoms can overlap.

Testing is needed because appearance alone cannot reliably distinguish the infections.

A person can also have more than one STI at the same time.

Samples may come from:

• urine;
• vaginal swabs;
• cervical swabs;
• urethral swabs;
• rectal samples in selected circumstances.

Testing should be directed by symptoms, sexual exposure, and local clinical guidance.

Routine screening of every person without symptoms is not always recommended.

• persistent urethritis;
• recurrent cervicitis;
• suspected PID;
• symptoms that continue after treatment for another STI.

A correct diagnosis helps avoid unnecessary antibiotics.

This is especially important because inappropriate antibiotic use can contribute to resistance.

Treatment can be more complicated than for some other bacterial STIs because the organism has developed resistance to several commonly used antibiotics.

Treatment may depend on:

• local guidelines;
• resistance testing when available;
• previous antibiotics;
• symptoms;
• pregnancy status;
• treatment history.

People should complete the prescribed course and avoid using leftover or unprescribed antibiotics.

The bacterium has no typical cell wall, so antibiotics that target bacterial cell walls are ineffective.

Resistance to other antibiotic classes has also increased.

For this reason, treatment may use:

• resistance-guided therapy;
• sequential antibiotic regimens;
• follow-up testing in selected cases.

Treatment recommendations can change as resistance patterns evolve.

Whether it is recommended depends on:

• the antibiotic regimen used;
• symptoms;
• local guidance;
• concern about resistance.

Testing too soon may be misleading, so timing matters.

Persistent symptoms after treatment should be medically reviewed.

Partner management may involve:

• testing;
• treatment when appropriate;
• discussion of symptoms;
• temporary avoidance of sexual contact.

This helps reduce the chance of reinfection.

A partner may carry Mgen without symptoms.

• treatment has been completed;
• symptoms have improved;
• relevant partners have been managed.

The exact recommendation may depend on local guidance and whether follow-up testing is planned.

Resuming sex too early may increase the risk of reinfection or continued transmission.

Condoms are especially useful because Mgen spreads through sexual contact involving genital secretions and mucosal surfaces.

Other prevention strategies include:

• STI testing when appropriate;
• treatment of infected partners;
• avoiding sexual contact during treatment;
• discussing sexual-health status with partners.

No prevention strategy eliminates every possible risk.

Rectal infection may cause:

• no symptoms;
• discomfort;
• inflammation in some cases.

Testing of rectal sites may be considered after relevant exposure, depending on symptoms and clinical guidance.

A urine test alone may not detect infection at every body site.

It may contribute to:

• cervicitis;
• PID;
• reproductive-tract inflammation.

Research continues regarding its relationship with infertility, pregnancy complications, and other outcomes.

Pregnant people with suspected or confirmed infection should receive individualized treatment advice because not all antibiotics are appropriate during pregnancy.

• many infections cause no symptoms;
• symptoms resemble other STIs;
• specialized testing may not always be immediately available;
• routine screening is not universal.

Persistent symptoms after negative or treated chlamydia and gonorrhea may prompt consideration of Mgen.

• poor hygiene;
• promiscuity;
• irresponsible behavior.

Like other STIs, it can spread during ordinary consensualsexual activity.

Because many infections are asymptomatic, people may transmit it without knowing.

Nonjudgmental testing and treatment encourage better sexual-health outcomes.

Mgen always causes symptoms.
No. Many people have no symptoms.

Any antibiotic will cure Mgen.
No. Antibiotic resistance makes treatment more complicated.

A negative urine test always excludes infection everywhere.
No. Infection may occur at another exposed body site.

Mgen only affects people with a penis.
No. It can infect people of different anatomies and may cause cervicitis or PID.

Having Mgen proves recent infidelity.
No. Asymptomatic infection can remain unnoticed, so the timing of transmission may be unclear.

1. Mycoplasma genitalium is a sexually transmitted bacterial infection.
2. Mgen can cause persistent urethritis or cervicitis.
3. Can Mycoplasma genitalium occur without symptoms?
4. Laboratory testing is usually needed for accurate diagnosis.
5. Antibiotic resistance can make Mgen difficult to treat.
6. Sexual partners may also need evaluation.
7. Condom use can reduce transmission risk.
8. Understanding Mycoplasma genitalium helps readers connect STI testing, antibiotic resistance, reproductive health, and safer sex.

Because many infections are asymptomatic, testing and partner communication can be important even when no obvious symptoms are present. Persistent urethritis, cervicitis, or pelvic symptoms may require specific testing rather than repeated empirical treatment.

Understanding Mgen supports accurate STI education, responsible antibiotic use, partner care, safer-sex practices, and nonjudgmental sexual-health communication.